The clinical laboratory service market value is projected to grow from USD 202.5 billion in 2021 and is projected to reach USD 315.61 billion by 2030; it is expected to grow at a CAGR of 5.1 % from 2021 to 2030.
The report contains 150+ pages with detailed analysis. The market report also covers the estimated market sizes and trends for different countries across major regions, globally.
The rapid growth of the research centers and increasing investments by the healthcare companies for the research and developmental activities results in reducing the complexity of current healthcare system.
Moreover, Clinical laboratory service system is registering it mark in the hospital, pharmacies, and health insurance sectors. The information based on these laboratory services are to make accurate decision while diagnose the patience. This is a major factor that boosts the growth of the global clinical laboratory service market.
Download the Sample Pages of this Report for Better Understanding (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/sample/1387
The factors which augment the market are rising incidence of chronic diseases and rising demand for accurate disease diagnoses. Further, the rising adoption of innovative and automated technologies in the healthcare sector is boosting the adoption of the clinical laboratory service across the globe. The Clinical laboratory service is expected to change the way the hospitals and pharmacies operate by introducing innovative and data-centric methods and insights. Moreover,the growing penetration of cloud-based services in the healthcare sector is complementing the growth of the Clinical laboratory service market across the globe.
Report Scope of the Clinical Laboratory Service Market
| Report Highlights | Details |
| Market Size in 2030 | USD 315.61 Billion |
| Growth Rate | CAGR of 5.1% From 2021 to 2030 |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2021 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Test Type, Service Provider, Application, Region |
Research Objective
the market revenue/volume with the help of widespread quantitative and qualitative insights, and forecasts of the market. This report presents breakdown of market into forthcoming and niche segments. Additionally, this research study gauges market revenue growth and its drift at global, regional, and country from 2017 to 2020. This research report evaluates clinical laboratory service market on a global and regional level.
It offers thorough analysis of market status, growth and forecast of the global clinical laboratory service market for the period from 2017 to 2030. This research study offers historic data for years 2017 to 2020 along with a forecast from 2021 to 2030 based on value.
This report also provides detailed company profiles of the key market players. This research report also highlights the competitive landscape of the clinical laboratory service market and ranks noticeable companies as per their occurrence in diverse regions across globe and crucial developments initiated by them in the market space.
This research study also tracks and evaluates competitive developments, such as collaborations, partnerships, and agreements, mergers and acquisitions; novel product introductions and developments, promotion strategies and Research and Development (R&D) activities in the marketplace. The competitive profiling of these players includes business and financial overview, gross margin, production, sales, and recent developments which can aid in assessing competition in the market.
North America dominated the market in 2020. This is attributed to the increased adoption rate of the latest technologies in the countries like US and Canada. The presence of high number of health care companies along with the various contract manufacturing organizations and contract research organizations is benefiting the market in this region.
The rising investment by the private players in the research activities for the development of various drugs for the treatment of chronic disease such as cancer, leukemia, lymphoma, muscular degeneration, and diabetes has necessitated the need for the efficient management of data and hence, the demand for the Clinical laboratory service increased rapidly in the region.
Asia Pacific is expected to be the most opportunistic market during the forecast period. The rising government expenditure to develop strong healthcare infrastructure and government policies to attract FDIs is expected to play a significant role in the growth of the Clinical laboratory service market in the region.
The presence of huge population and rising number of hospital admissions will foster the demand for the Clinical laboratory service systems in the Asia Pacific region, and will lead to the growth of the market during the forecast period.
The rising prevalence of chronic diseases among the population will boost the demand for the health care services, pharmacies, and health insurances. Moreover, the increasing patient awareness, evolution to pathogens, advanced in area of healthcare and biotechnology in genomics & proteomics are the driving factors for the growth of the market.
The high costs associated with the acquisition of the latest clinical laboratory service may hamper the growth of the market. Further, lack of adequate infrastructure and capital in the underdeveloped and developing nations may hamper the market growth during the forecast period.
The introduction of latest technologies such as artificial intelligence and machine learning may provide growth prospects to the market players in the upcoming future, and drive the market growth.
Based on the type, the clinical chemistry segment is the leading and the fastest-growing segment. This can be attributed to the increasing investments in the research activities for the development of life-saving drugs and diagnosis procedures to treat various chronic diseases prevalent among the global population.
Based on the service provider, the hospital-based laboratories segment dominated the market. This can be attributed to the increased research activities and increased treatment of the cancer patients in the hospitals.According to the International Agency for Research on Cancer, in 2020, around 19.3 million new cancer cases and 10 million cancer deaths were reported across the globe.
Based on the application, the bioanalytical and lab chemistry services segment was the leading segment in 2020. The rising prevalence of diseases coupled with the increased number of hospital admissions has significantly contributed towards the growth of this segment in the past few years. Moreover, rising investments for the development of better and improve healthcare infrastructure is boosting the growth of the hospitals especially in the developing regions.
Some of the prominent players in the global clinical laboratory service market include:
- Qiagen
- Quest Diagnostics, Inc
- OPKO Health, Inc
- Abbott
- Charles River Laboratories; International, Inc
- Cinven
- Arup Laboratories
- Sonic Healthcare
- Laboratory Corporation of America Holdings (LabCorp)
- NeoGenomics Laboratories, Inc.
Read Also: Power Electronics Market is Expected to Grow at a 5.2% CAGR By 2030
Segments Covered in the Report
By Test Type
- Human & Tumor Genetics
- Clinical Chemistry
- Medical Microbiology & Cytology
- Other Esoteric Tests
By Service Provider
- Hospital-Based Laboratories
- Stand-Alone Laboratories
- Clinic-Based Laboratories
By Application
- Bioanalytical& Lab Chemistry Services
- Toxicology Testing Services
- Cell & Gene Therapy Related Services
- Preclinical & Clinical Trial Related Services
- Drug Discovery & Development Related Services
- Others
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of the World
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Clinical Laboratory Service Market
5.1. COVID-19 Landscape: Clinical Laboratory Service Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Clinical Laboratory Service Market, By Test
8.1. Clinical Laboratory Service Market, by Test Type, 2021-2030
8.1.1. Human & Tumor Genetics
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Clinical Chemistry
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Medical Microbiology & Cytology
8.1.3.1. Market Revenue and Forecast (2019-2030)
8.1.4. Other Esoteric Tests
8.1.4.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Clinical Laboratory Service Market, By Application
9.1. Clinical Laboratory Service Market, by Application, 2021-2030
9.1.1. Bioanalytical& Lab Chemistry Services
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Toxicology Testing Services
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Cell & Gene Therapy Related Services
9.1.3.1. Market Revenue and Forecast (2019-2030)
9.1.4. Preclinical & Clinical Trial Related Services
9.1.4.1. Market Revenue and Forecast (2019-2030)
9.1.5. Drug Discovery & Development Related Services
9.1.5.1. Market Revenue and Forecast (2019-2030)
9.1.6. Others
9.1.6.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Clinical Laboratory Service Market, By Service Provider
10.1. Clinical Laboratory Service Market, by Service Provider, 2021-2030
10.1.1. Hospital-Based Laboratories
10.1.1.1. Market Revenue and Forecast (2019-2030)
10.1.2. Stand-Alone Laboratories
10.1.2.1. Market Revenue and Forecast (2019-2030)
10.1.3. Clinic-Based Laboratories
10.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 11. Global Clinical Laboratory Service Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Test (2019-2030)
11.1.2. Market Revenue and Forecast, by Application (2019-2030)
11.1.3. Market Revenue and Forecast, by Service Provider (2019-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Test (2019-2030)
11.1.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.1.4.3. Market Revenue and Forecast, by Service Provider (2019-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Test (2019-2030)
11.1.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.1.5.3. Market Revenue and Forecast, by Service Provider (2019-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Test (2019-2030)
11.2.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.3. Market Revenue and Forecast, by Service Provider (2019-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Test (2019-2030)
11.2.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.4.3. Market Revenue and Forecast, by Service Provider (2019-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Test (2019-2030)
11.2.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.5.3. Market Revenue and Forecast, by Service Provider (2019-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Test (2019-2030)
11.2.6.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.6.3. Market Revenue and Forecast, by Service Provider (2019-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Test (2019-2030)
11.2.7.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.7.3. Market Revenue and Forecast, by Service Provider (2019-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Test (2019-2030)
11.3.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.3. Market Revenue and Forecast, by Service Provider (2019-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Test (2019-2030)
11.3.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.4.3. Market Revenue and Forecast, by Service Provider (2019-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Test (2019-2030)
11.3.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.5.3. Market Revenue and Forecast, by Service Provider (2019-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Test (2019-2030)
11.3.6.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.6.3. Market Revenue and Forecast, by Service Provider (2019-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Test (2019-2030)
11.3.7.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.7.3. Market Revenue and Forecast, by Service Provider (2019-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Test (2019-2030)
11.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.3. Market Revenue and Forecast, by Service Provider (2019-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Test (2019-2030)
11.4.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.4.3. Market Revenue and Forecast, by Service Provider (2019-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Test (2019-2030)
11.4.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.5.3. Market Revenue and Forecast, by Service Provider (2019-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Test (2019-2030)
11.4.6.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.6.3. Market Revenue and Forecast, by Service Provider (2019-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Test (2019-2030)
11.4.7.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.7.3. Market Revenue and Forecast, by Service Provider (2019-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Test (2019-2030)
11.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.5.3. Market Revenue and Forecast, by Service Provider (2019-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Test (2019-2030)
11.5.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.5.4.3. Market Revenue and Forecast, by Service Provider (2019-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Test (2019-2030)
11.5.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.5.5.3. Market Revenue and Forecast, by Service Provider (2019-2030)
Chapter 12. Company Profiles
12.1. Qiagen
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Quest Diagnostics, Inc
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. OPKO Health, Inc
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Abbott
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Charles River Laboratories; International, Inc
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Cinven
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Arup Laboratories
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Sonic Healthcare
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Laboratory Corporation of America Holdings (LabCorp)
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. NeoGenomics Laboratories, Inc.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1387
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
